Related Experiment Video

Updated: Oct 1, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K

Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity

Aviad Ben-Shmuel1, Batel Sabag1, Abhishek Puthenveetil1

  • 1The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.

Elife
|March 8, 2022
PubMed

Insights

This study reveals how protein kinase C-theta (PKC-θ) regulates Natural Killer (NK) cell activity by phosphorylating SHP-1. Suppressing PKC-θ maintains NK cell activation, enhancing anti-tumor immunity.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Natural Killer (NK) cells are vital for innate immunity, eliminating virally infected and cancerous cells.
  • NK cell function relies on balancing activating and inhibitory signals, but regulatory mechanisms are not fully understood.
  • SHP-1 tyrosine phosphatase is a key negative regulator of NK cell activity, though its own regulation is unclear.

Purpose of the Study:

  • To elucidate the regulatory pathways controlling SHP-1 activity in NK cells.
  • To investigate the role of protein kinase C-theta (PKC-θ) in modulating SHP-1 function and NK cell responses.

Main Methods:

  • Phosphorylation site analysis of SHP-1 in NK cells.
  • Silencing of PKC-θ using genetic or pharmacological approaches.
  • Assessment of NK cell activation, cytotoxicity, and tumor progression in vivo.

Main Results:

  • Phosphorylation of SHP-1 at the S591 residue by PKC-θ induces an inhibited 'folded' state.
  • Silencing PKC-θ preserves SHP-1 in its active conformation.
  • PKC-θ inhibition leads to reduced NK cell activation and cytotoxicity, promoting tumor growth.

Conclusions:

  • PKC-θ acts as a critical regulator of NK cell activation threshold by controlling SHP-1 activity.
  • This pathway represents a potential target for enhancing NK cell-mediated anti-tumor immunity.
Keywords:
PKCSHP-1cancerhumanimmunologyinflammationnatural killersignaling

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

15.3K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
4.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K